We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Transfusion Management System Assures Patient Safety

By Labmedica staff writers
Posted on 29 Jul 2008
A point-of-care (POC) transfusion safety management system assists nurses, phlebotomists, and laboratory personnel in assuring that blood samples are drawn from correct patients and administered to suitable patients. More...


The new POC transfusion safety-management system is composed of computers, a software application, wireless handheld barcode scanners, and wireless printers. In addition to helping laboratory personnel in the accurate matching of blood samples with correct blood or blood products, it enables immediate documentation of any adverse reaction data.

A product of IntelliDOT Corp. (San Diego, CA, USA), the management system is called the IntelliDOT blood product administration (IntelliDOT BPA). The company announced that the U.S. Food and Drug Administration (FDA; Rockville, MD, USA) granted 510(k) clearance for the IntelliDOT BPA for commercial sale.

"The FDA approval for IntelliDOT blood product administration advances our corporate mission to provide innovative and easy-to-adopt, point-of-care solutions to enhance patient safety, improve nurse efficiency, and help hospitals reduce risk and liability,” said Thomas G. Klopack, president and CEO of IntelliDOT. "With this latest addition, IntelliDOT extends its ability to support improved quality of care across the full spectrum of patient needs.”

IntelliDOT BPA is an integrated module of the IntelliDOT CAREt system, the manager that connects caregivers with the information systems they need at the point-of-care. The other currently available modules in the CAREt system include: IntelliDOT bedside medication administration, IntelliDOT phlebotomy specimen collection, IntelliDOT mother-baby breast milk matching, and IntelliDOT vital signs collection.

IntelliDOT is a provider of wireless, handheld, barcode point-of- care (BPOC) solutions that connect to any healthcare information system to improve patient safety and nurse workflow. When using the IntelliDOT system, nurses can easily manage all tasks associated with medication-administration safety checks and related documentation.


Related Links:
U.S. Food and Drug Administration
IntelliDOT

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Online QC Software
Acusera 24•7
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.